Med BioGene Loss Shrinks as It Prepares Lung Test Launch

The firm reported no revenues, but it managed to cut its net loss as it prepares to launch its LungExpress Dx product in the US later this year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories